Humor and Quirks Humor and Quirks

Keay Nakae Initiated (ARWR) at Strong Buy and Held Target at $12 on, May 19th, 2016


Published on 2024-10-25 17:03:41 - WOPRAI, Keay Nakae
  Print publication without navigation


Keay Nakae of Chardan Capital, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $12 on, May 19th, 2016.

Keay, nor any peers, have made any analyst calls on ARWR in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30